ZAROXOLYN

This brand name is authorized in Canada, Estonia.

Active ingredients

The drug ZAROXOLYN contains one active pharmaceutical ingredient (API):

1	Metolazone UNII TZ7V40X7VX - METOLAZONE
	Metolazone is a diuretic antihypertensive drug for the treatment of edema. Metolazone is a quinazoline diuretic, with properties generally similar to the thiazide diuretics. The actions of metolazone result from interference with the renal tubular mechanism of electrolyte reabsorption.
	Read more about Metolazone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ZAROXOLYN Tablet	MPI, EU: SmPC	Health Products and Food Branch (CA)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C03BA08	Metolazone	C Cardiovascular system → C03 Diuretics → C03B Low-ceiling diuretics, excl. thiazides → C03BA Sulfonamides, plain
Discover more medicines within C03BA08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	00888400
EE	Ravimiamet	1730966